Discover our new oral solid dose (OSD) development capabilities at our Bend, Oregon site.
Our highly experienced local Tokyo team has an exceptional commitment to quality, deeply instilled ethics of personal responsibility and local expertise, with a true appreciation of cultural nuances.
Supported by our network of Asia Pacific facilities, including Beijing & Suzhou in China, India, Korea and Singapore, we provide access to a global network with a local presence.
We work closely with clinical trial Sponsors to define the best distribution model for each study, realizing cost and performance efficiencies across the entire Asia Pacific supply chain.
Download the site capabilities fact sheet to learn more about this location.
1-12-10 Shinkiba, Koto-ku
Tokyo 136-0082, Japan